Forensic Practice Intelligence
Defending Clinical EBITDA Through Profitability Forensics.
You are fighting a two-front war. Payer algorithms are denying claims while institutional buyers weaponize the same data to compress your multiple. We build the forensic data architecture that neutralizes Phantom EBITDA before it reaches the closing table.
The Data Architecture Framework
Two operational pillars.
One auditable outcome.
Every PDA engagement maps to one of two forensic tracks — each benchmarked against a 2,500-practice national baseline and designed to produce institutional-grade, QoE-defensible results.
Financial Forensics
EBITDA Normalization & QoE Defense
Payer algorithms denied 11.8% of claims in 2024 — up from 10.2% — while only 1% were ever appealed. The same algorithmic scrutiny that erodes your collections today will appear in a buyer's QoE audit tomorrow. We extract your raw data, locate unsanitized write-offs and coding anomalies, and benchmark your margins against a 2,500-practice national baseline before a buyer does it for you.
Clinical Growth Architecture
Capacity, Case Acceptance & Revenue Scaling
Insurers are converting clinical judgment into algorithmic data points — conducting automated due diligence on every claim at industrial scale. From closing the case acceptance gap to optimizing hygiene profitability to engineering De Novo builds to $2M+, we deploy data-dictated SOPs that replace personality-driven management with auditable, owner-independent systems.
Self-Service Diagnostics
Stop guessing. Quantify your exposure.
Two proprietary tools built on the same benchmarking framework we deploy in full engagements. Score your practice in minutes — before a buyer scores it for you.
EBITDA Leakage Calculator
Overhead Structure & Margin Forensics
Score your overhead structure against institutional benchmarks. Identify the exact categories bleeding margin — and quantify the EBITDA you're leaving undefended.
Valuation Calculator
Enterprise Value & Multiple Estimation
Estimate your practice's enterprise value using EBITDA-based methodology with growth, risk, and market adjustment factors. See the number a buyer's model will produce.
The Benchmarking Framework
11 domains. 2,500-practice baseline.
Your exact position.
The KPI Intelligence Framework maps every revenue-critical metric from patient acquisition through valuation architecture. Each domain is benchmarked with percentile rankings against our national database.
Revenue Per Practice
The Research Foundation
Built on five definitive industry texts.
The frameworks deployed at Precision Dental Analytics aren't theoretical — they're codified from two decades of operational reality at the highest levels of DSO consolidation, turnaround mandates, and institutional M&A.
Meet the Team
The Data Driven Dentist
Latest Intelligence.
Financial Analytics
How DSOs Actually Evaluate Your Dental Practice: The 11 Underwriting Criteria They Score But Never Publish
Former NADG regional director reveals the 11 criteria DSO underwriting teams actually score — and the specific thresholds that separate premium multiples from discount ones.
Industry Insights
The Same Playbook: What a Harvard Hospital Study Tells Us About the Future of Dental Practice Valuations
A Harvard study on PE-owned hospitals revealed a 13% rise in ER deaths after acquisition. The same debt-loading, cost-cutting playbook runs in dental M&A — and understanding it is the difference between a defended exit and a seven-figure re-trade.
Financial Analytics
Governance Debt: The Compounding Liability Silently Eroding Your Practice's Enterprise Value
Governance debt — compliance gaps, undocumented SOPs, key-person risk — compounds silently and surfaces during due diligence. Here's how to quantify and eliminate it before a buyer's algorithm does.
The Data Driven Dentist Newsletter
James & Joe write here first.
5,000+ dental operators and M&A participants subscribe. This is the only place you get both perspectives — clinical architecture and analytics validation — in one newsletter.
The Next Step
Your data is telling a story.
Are you reading it?
Most founders go to market expecting a 10x platform valuation, unaware that their clinical data is fragmented. Buyers don't pay for clinical potential — they pay for auditable reality.
Confidential intake. Typically responded to within 48 hours.